D J Grunhagen
Overview
Explore the profile of D J Grunhagen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hakkesteegt S, Oudmaijer C, Jeletich L, Sprakel J, Kimenai H, Grunhagen D
Clin Case Rep
. 2025 Jan;
13(1):e9681.
PMID: 39807225
Soft tissue sarcomas (STSs) are rare malignancies, with retroperitoneal soft tissue sarcoma (RPS) constituting 10%-15% of all STSs. RPS often presents late due to minimal early symptoms, typically requiring complete...
2.
Janssen J, van Dijk B, Hoeijmakers L, Grunhagen D, Bramer W, Verhoef C, et al.
Cancer Treat Rev
. 2024 Nov;
131:102848.
PMID: 39486396
Since the introduction of immune checkpoint inhibitors (ICIs) targeting PD-1 and CTLA-4 receptors, survival has improved significantly for patients with irresectable and metastatic skin cancer, including cutaneous squamous cell cancer...
3.
Spaanderman D, Hakkesteegt S, Hanff D, Schut A, Schiphouwer L, Vos M, et al.
EClinicalMedicine
. 2024 Oct;
76:102802.
PMID: 39351025
Background: As differentiating between lipomas and atypical lipomatous tumors (ALTs) based on imaging is challenging and requires biopsies, radiomics has been proposed to aid the diagnosis. This study aimed to...
4.
Filipe W, Meyer Y, Buisman F, van den Braak R, Galjart B, Hoppener D, et al.
Ann Surg Oncol
. 2023 Oct;
30(13):7996-8005.
PMID: 37782413
Background: Histopathological growth patterns (HGPs) are a prognostic biomarker in colorectal liver metastases (CRLM). Desmoplastic HGP (dHGP) is associated with liver-only recurrence and superior overall survival (OS), while non-dHGP is...
5.
IJzerman N, van Werkhoven E, Mohammadi M, Hollander D, Bleckman R, Reyners A, et al.
ESMO Open
. 2022 Dec;
7(6):100649.
PMID: 36493601
Background: Sex differences in cancer have gained attention in recent years. The role of sex as a prognostic factor in gastrointestinal stromal tumours (GIST) has not been well established. The...
6.
Meyer Y, Wilting S, Kraan J, Olthof P, Vermeulen P, Martens J, et al.
Clin Exp Metastasis
. 2022 Nov;
40(1):69-77.
PMID: 36326981
Histopathological Growth Patterns (HGPs) have prognostic and predictive value in patients with Colorectal Liver Metastases (CRLM). This study examined whether preoperative measurement of Circulating Tumour Cells (CTCs) is associated with...
7.
Derks S, de Joode K, Mulder E, Ho L, Joosse A, de Jonge M, et al.
ESMO Open
. 2022 Oct;
7(6):100600.
PMID: 36265261
Background: The incidence of melanoma is increasing and 37% of patients with metastatic melanoma eventually have brain metastasis (BM). Currently, there is no consensus on screening for BM in patients...
8.
van Praag V, Fiocco M, Bleckman R, van Houdt W, Haas R, Verhoef C, et al.
Eur J Surg Oncol
. 2022 Sep;
49(2):339-344.
PMID: 36085118
Introduction: Patients with locally extensive high-grade extremity soft tissue sarcomas (eSTS) are often presented in multidisciplinary teams to decide between ablative surgery (amputation) or limb-salvage surgery supplemented with either neo-adjuvant...
9.
Korenblik R, Olij B, Aldrighetti L, Abu Hilal M, Ahle M, Arslan B, et al.
Cardiovasc Intervent Radiol
. 2022 Jul;
45(9):1391-1398.
PMID: 35790566
Study Purpose: The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients...
10.
van de Geest T, van Amerongen M, Nierop P, Hoppener D, Grunhagen D, Moelker A, et al.
Eur J Surg Oncol
. 2022 Jan;
48(6):1368-1374.
PMID: 35078702
Purpose: Minimally invasive ablative treatments, such as radiofrequency ablation (RFA), are increasingly used in the curative treatment of patients with colorectal liver metastases (CRLM). Selection bias plays an important role...